株探米国株
英語
エドガーで原本を確認する
false 0001301787 0001301787 2025-05-15 2025-05-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

  

FORM 8-K

  

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):    May 21, 2025 (May 15, 2025)

 

 

 

BlueLinx Holdings Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-32383   77-0627356

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

1950 Spectrum Circle, Suite 300, Marietta, Georgia   30067
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (770) 953-7000

 

_________________________________________________

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share BXC New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 


 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

On May 15, 2025, BlueLinx Holdings Inc. (the “Company”) held its Annual Meeting of Stockholders (the “2025 Annual Meeting”) to (1) elect eight directors to hold office until the Company’s 2026 Annual Meeting of Stockholders, or until their successors are duly elected and qualified; (2) to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the Company’s current fiscal year ending January 3, 2026; and (3) approve an advisory, non-binding resolution regarding the executive compensation described in the Company’s Proxy Statement for the 2025 Annual Meeting.

 

At the close of business of March 18, 2025, the record date of the 2025 Annual Meeting, an aggregate of 8,180,454 shares of the Company’s common stock were issued and outstanding. At the meeting, 7,256,822 shares of the Company’s common stock were represented in person or by proxy; therefore, a quorum was present.

 

At the 2025 Annual Meeting, the Company’s stockholders voted as follows:

 

(1) For the election of the below-named nominees to the Board of Directors of the Company:

 

Nominees   Number of
Votes For
    Number of
Votes
    Broker
Non-Votes
 
Anuj Dhanda     5,419,138       912,281       925,403  
Kim S. Fennebresque     5,737,886       593,533       925,403  
Keith A. Haas     6,204,562       126,857       925,403  
Mitchell B. Lewis     5,831,677       499,742       925,403  
Shyam K. Reddy     6,187,646       143,773       925,403  
J. David Smith     6,192,396       139,023       925,403  
Carol B. Yancey     6,213,544       117,875       925,403  
Marietta Edmunds Zakas     5,775,245       556,174       925,403  

 

(2) For the ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the Company’s current fiscal year ending January 3, 2026:

 

For     Against     Abstain  
  7,204,805       50,020       1,997  

 

(3) For the approval of the advisory, non-binding resolution regarding the executive compensation described in the Company’s Proxy Statement for the 2025 Annual Meeting:

 

For     Against     Abstain     Broker Non-Votes  
  5,759,701       562,625       9,093       925,403  

 

Accordingly, the Company’s stockholders elected the eight director nominees and approved proposals 2 and 3 at the 2025 Annual Meeting.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)       Exhibits:

 

The following exhibits are attached with this Current Report on Form 8-K:

 

Exhibit No.   Exhibit Description
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    BlueLinx Holdings Inc.
     
Dated: May 21, 2025 By:  /s/ Shyam K. Reddy
    Shyam K. Reddy
    President and Chief Executive Officer